Pantanetti, P.; Ronconi, V.; Mancin, S.; De Carolis, C.; Alberti, S.; Pazzi, O.; Di Marco, S.; Michetti, G.; Coacci, S.; Mignini, V.;
et al. Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy. Diabetology 2025, 6, 80.
https://doi.org/10.3390/diabetology6080080
AMA Style
Pantanetti P, Ronconi V, Mancin S, De Carolis C, Alberti S, Pazzi O, Di Marco S, Michetti G, Coacci S, Mignini V,
et al. Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy. Diabetology. 2025; 6(8):80.
https://doi.org/10.3390/diabetology6080080
Chicago/Turabian Style
Pantanetti, Paola, Vanessa Ronconi, Stefano Mancin, Cristina De Carolis, Sara Alberti, Orietta Pazzi, Sandra Di Marco, Grazia Michetti, Silvia Coacci, Veronica Mignini,
and et al. 2025. "Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy" Diabetology 6, no. 8: 80.
https://doi.org/10.3390/diabetology6080080
APA Style
Pantanetti, P., Ronconi, V., Mancin, S., De Carolis, C., Alberti, S., Pazzi, O., Di Marco, S., Michetti, G., Coacci, S., Mignini, V., Gregorio, F., Baldoni, G., Toderi, S., Morales Palomares, S., Petrelli, F., Caggianelli, G., Parozzi, M., & Cangelosi, G.
(2025). Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy. Diabetology, 6(8), 80.
https://doi.org/10.3390/diabetology6080080